SCHEMBL3479608

SCHEMBL3479608

CN1CCN(c2ccc(F)cc2F)c2ccc(N3CCNCC3)cc2C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
HTR1A P08908 3/20 0.40
HTR7 P34969 1/20 0.40
ADRB1 P08588 4/20 0.39
SLC6A2 P23975 1/20 0.39
SLC6A4 P31645 1/20 0.39
SLC6A3 Q01959 1/20 0.39
IDO1 P14902 2/20 0.38
TDO2 P48775 2/20 0.38
IDO2 Q6ZQW0 2/20 0.38
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA4 P22748 1/20 0.37
CA6 P23280 1/20 0.37
CA5A P35218 1/20 0.37
CA7 P43166 1/20 0.37
CA9 Q16790 1/20 0.37
CA13 Q8N1Q1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3479662 0.92 ALDH1A1 (0.50) ALDH1A1L3MBTL1IDO1TDO2IDO2
SCHEMBL3479410 0.89 HTR1A (0.45) ALDH1A1L3MBTL1HTR1AHTR7ADRB1
SCHEMBL3479645 0.88 HTR3A (0.41) HTR1AHTR7ADRB1KDM4EGAA
SCHEMBL3227983 0.86 SMN1; SMN2 (0.44) ALDH1A1L3MBTL1SLC6A2SLC6A4SLC6A3
SCHEMBL3479564 0.86 ADRB1 (0.40) ALDH1A1L3MBTL1HTR1AHTR7ADRB1
SCHEMBL3479783 0.85 ADRB1 (0.40) HTR1AHTR7ADRB1SLC6A4KDM4E
SCHEMBL3234227 0.84 ALDH1A1 (0.50) ALDH1A1L3MBTL1SLC6A2SLC6A4SLC6A3
SCHEMBL3235474 0.82 RORC (0.45) ALDH1A1L3MBTL1KDM4EGAAMAPT
SCHEMBL3222197 0.81 ADAMTS4 (0.42) ALDH1A1L3MBTL1SLC6A2SLC6A4SLC6A3
SCHEMBL3239201 0.81 ADRB1 (0.47) HTR1AHTR7ADRB1SLC6A4HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096546-B2 Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin ALBANY MOLECULAR RESEARCH, INC. (US) 2015-08-04 US disclosed
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ALBANY MOLECULAR RESEARCH, INC. (US) 2010-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ADRA1B, ADRB1, ADRA1D ALDH1A1 372/4885L3MBTL1 2286/4885HTR1A 16/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.